THQ
Abrdn Healthcare Opportunities Fund·NYSE
--
--(--)
--
--(--)
THQ fundamentals
During FY 2025, Abrdn Healthcare Opportunities Fund (THQ) reported revenue of 21.43M, a YoY change of -9.72%. Net income was -114.84M, a YoY change of -160.58%. Click to view the full income statement and explore the company's earnings performance.
Income Statement
H1,2020 | FY,2020 | H1,2021 | FY,2021 | H1,2022 | FY,2022 | H1,2023 | FY,2023 | H1,2024 | FY,2024 | H1,2025 | FY,2025 | TTM |
|---|
Start Date | Oct 1, 2019 | Oct 1, 2019 | Oct 1, 2020 | Oct 1, 2020 | Oct 1, 2021 | Oct 1, 2021 | Oct 1, 2022 | Oct 1, 2022 | Oct 1, 2023 | Oct 1, 2023 | Oct 1, 2024 | Oct 1, 2024 | -- |
End Date | Mar 31, 2020 | Sep 30, 2020 | Mar 31, 2021 | Sep 30, 2021 | Mar 31, 2022 | Sep 30, 2022 | Mar 31, 2023 | Sep 30, 2023 | Mar 31, 2024 | Sep 30, 2024 | Mar 31, 2025 | Sep 30, 2025 | -- |
Fiscal Year-End | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 | -- |
Revenue | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 23.60M -- | 12.15M -- | 23.74M +0.61% | -- -- | 21.43M -9.72% | 21.43M -- |
Operating Expenses | 6.14M -- | 12.24M -- | 6.36M +3.61% | 13.56M +10.79% | 6.89M +8.35% | 13.85M +2.11% | 12.98M +88.38% | 12.98M -6.22% | 6.31M -51.38% | 12.66M -2.50% | 6.12M -3.10% | 11.41M -9.89% | 11.41M -- |
Selling, General and Administrative Expenses | 532.57K -- | 1.08M -- | 552.41K +3.73% | 1.19M +10.26% | 643.18K +16.43% | 1.38M +15.78% | 1.19M +84.36% | 1.19M -13.79% | 283.90K -76.06% | 397.40K -66.49% | 173.40K -38.92% | 261.22K -34.27% | 261.22K -- |
Other Operating Expenses | 5.61M -- | 11.16M -- | 5.81M +3.60% | 12.37M +10.84% | 6.25M +7.58% | 12.47M +0.80% | 11.80M +88.79% | 11.80M -5.39% | 6.03M -48.90% | 12.26M +3.93% | 5.94M -1.42% | 11.15M -9.10% | 11.15M -- |
Operating Income | -25.28M -- | 116.64M -- | 119.82M +574.03% | 194.65M +66.88% | 37.14M -69.00% | -86.25M -144.31% | 52.79M +42.12% | 52.79M +161.20% | 123.37M +133.72% | 189.56M +259.11% | -60.91M -149.37% | -114.84M -160.58% | -114.84M -- |
Non-Operating Income (Loss) | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 45.50K -- | -- -- | -- -- | -- -- | -- -- |
Gain (Loss) on Change in Fair Value | -29.43M -- | 66.26M -- | 106.34M +461.33% | 131.41M +98.31% | 26.55M -75.03% | -138.16M -205.13% | -1.65M -106.22% | -1.65M +98.81% | 122.98M +7552.76% | 150.99M +9249.88% | -68.58M -155.76% | -105.80M -170.07% | -105.80M -- |
Gain (Loss) on Foreign Currency Exchange | 3.34K -- | 3.34K -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Other Non-Operating Income (Loss) | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 45.50K -- | -- -- | -- -- | -- -- | -- -- |
Interest Expense | 3.00M -- | 4.65M -- | 1.07M -64.41% | 2.13M -54.23% | 1.26M +17.95% | 3.83M +79.72% | 13.09M +939.53% | 13.09M +242.25% | 7.52M -42.59% | 14.97M +14.36% | 6.61M -12.10% | 12.91M -13.77% | 12.91M -- |
Interest Income | 11.46M -- | 22.07M -- | 10.38M -9.42% | 22.20M +0.62% | 8.09M -22.08% | 18.14M -18.29% | 23.60M +191.65% | 23.60M +30.08% | 12.15M -48.53% | 23.74M +0.61% | 11.90M -2.01% | 21.43M -9.72% | 21.43M -- |
Pretax Income From Continuing Operations | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -2.48M -- | -1.64M -- | -3.89M -56.97% | -- -- | -2.89M +25.84% | -2.89M -- |
Net Income | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 52.79M -- | 123.42M -- | 189.56M +259.11% | -- -- | -114.84M -160.58% | -114.84M -- |
Net Income Attributable to Owners of the Company | -25.28M -- | 116.64M -- | 119.82M +574.03% | 194.65M +66.88% | 37.14M -69.00% | -86.25M -144.31% | 52.79M +42.12% | 52.79M +161.20% | 123.42M +133.81% | 189.56M +259.11% | -60.91M -149.35% | -114.84M -160.58% | -114.84M -- |
Net Income Attributable to Common Stockholders | -25.28M -- | 116.64M -- | 119.82M +574.03% | 194.65M +66.88% | 37.14M -69.00% | -86.25M -144.31% | 52.79M +42.12% | 52.79M +161.20% | 123.42M +133.81% | 189.56M +259.11% | -60.91M -149.35% | -114.84M -160.58% | -114.84M -- |
Basic EPS | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 4.58 -- | -- -- | -2.78 -160.70% | -2.78 -- |
You can ask Aime
What factors drove the changes in Abrdn Healthcare Opportunities Fund's revenue and profit?What does Abrdn Healthcare Opportunities Fund do and what are its main business segments?What is Abrdn Healthcare Opportunities Fund's gross profit margin?What is the market's earnings forecast for Abrdn Healthcare Opportunities Fund next quarter?What is Abrdn Healthcare Opportunities Fund's latest dividend and current dividend yield?Did Abrdn Healthcare Opportunities Fund beat or miss consensus estimates last quarter?What is the revenue and EPS growth rate for Abrdn Healthcare Opportunities Fund year over year?What were the key takeaways from Abrdn Healthcare Opportunities Fund’s earnings call?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
